BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31364714)

  • 1. 'Valvular' AL amyloidosis.
    Jozsa C; Lloyd G; Bhattacharyya S
    Eur Heart J; 2019 Dec; 40(45):3717. PubMed ID: 31364714
    [No Abstract]   [Full Text] [Related]  

  • 2. A man with easy bruising, heart failure, and organomegaly.
    Tolkachjov SN; Lehman JS
    Int J Dermatol; 2018 Dec; 57(12):1439-1441. PubMed ID: 29774527
    [No Abstract]   [Full Text] [Related]  

  • 3. Macroglossia in Light-Chain Amyloidosis.
    Melo Alves J; Marto N
    N Engl J Med; 2018 Jun; 378(24):2321. PubMed ID: 29897852
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heart transplantation in AL amyloidosis].
    Dahlberg P; Bartfay SE; Karason K; Mellqvist UH; Bollano E
    Lakartidningen; 2018 Mar; 115():. PubMed ID: 29583159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.
    Draghici M; Jercan A; Badelita SN; Irimia RM; Bastian AE; Dobrea C; Popescu M; Coriu D
    Medicine (Baltimore); 2021 Dec; 100(51):e28267. PubMed ID: 34941106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 49-Year-Old Woman With Progressive Dyspnea.
    Dai HL; Zhang WH; Guang XF
    JAMA Cardiol; 2022 Feb; 7(2):e214920. PubMed ID: 35138332
    [No Abstract]   [Full Text] [Related]  

  • 7. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
    Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
    Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroglossia as the initial presentation of AL amyloidosis: review and updates in treatment.
    Cherico AS; Rizvi A; Jayakrishnan T; Mewawalla P
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35817492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic amyloidosis-induced nail dystrophy.
    Jo G; Shin DY; Mun JH
    J Dtsch Dermatol Ges; 2019 Oct; 17(10):1057-1059. PubMed ID: 31538714
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloid cast nephropathy with systemic AL amyloidosis.
    Mizuno S; Kosukegawa H
    Int J Hematol; 2021 Jan; 113(1):1-2. PubMed ID: 33222047
    [No Abstract]   [Full Text] [Related]  

  • 11. Macroglossia Associated With Primary Systemic Amyloidosis - Case Report With Unusual Clinical Presentation.
    Muniyan S; Nair Sreela LS; Mathew P; Prasad T; Nair AS; Jose M
    J Ayub Med Coll Abbottabad; 2022; 34(1):197-199. PubMed ID: 35466653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
    Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
    Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictive cardiomyopathy and pseudoxanthoma elasticum skin lesions.
    Musumeci MB; Semprini L; Casenghi M; Montesanti D; Mastromarino V; Socciarelli F; Volpe M; Autore C
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e193-e195. PubMed ID: 25036271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloidosis: clinical pentad.
    Mookadam F; Mookadam M; Jiamsripong P
    Intern Med J; 2011 Jan; 41(1a):66-7. PubMed ID: 21265964
    [No Abstract]   [Full Text] [Related]  

  • 15. Macroglossia as the only presenting feature of amyloidosis due to MGUS.
    Tsourdi E; Därr R; Wieczorek K; Röcken C; Ehehalt F; Conrad K; Platzbecker U; Hofbauer LC
    Eur J Haematol; 2014 Jan; 92(1):88-9. PubMed ID: 23799910
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiac amyloidosis - important differential diagnosis in heart failure].
    Morbach C; Steinhardt M; Störk S
    Dtsch Med Wochenschr; 2022 Nov; 147(23):1522-1530. PubMed ID: 36384153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of heart failure in transthyretin vs. light chain amyloidosis.
    Binder C; Duca F; Stelzer PD; Nitsche C; Rettl R; Aschauer S; Kammerlander AA; Binder T; Agis H; Kain R; Hengstenberg C; Mascherbauer J; Bonderman D
    Eur Heart J Cardiovasc Imaging; 2019 May; 20(5):512-524. PubMed ID: 30649240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors in light chain amyloidosis].
    Jávorniczky NR; Bodó I; Masszi T; Mikala G
    Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pathologic analysis of light-chain (AL) amyloidosis in 7 patients].
    Liu T; Hu A; Yuan H
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):260-1. PubMed ID: 24915818
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.
    von Keudell G; Sanchorawala V; O'Hara C; C Seldin D; Sloan JM
    Amyloid; 2014 Jun; 21(2):124-7. PubMed ID: 24471777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.